Literature DB >> 1132888

Serum factors capable of opsonizing Shigella for phagocytosis by polymorphonuclear neutrophils.

W P Reed.   

Abstract

Twenty-five Shigella strains were tested for their susceptibility to phagocytosis and killing by polymorphonuclear neutrophils (PMN). The studies identified several serum factors that could participate in opsonization. The strains varied remarkably in their susceptibility to killing when heat-stable opsonins were employed, but all strains were killed when exposed to heat-labile opsonins and PMN. The heat-stable opsonin was shown to be IgG, whereas IgM was ineffective in the absence of complement, and 11S IgA was never effective. Heat labile opsonization required immunoglobulin as well as complement, but IgM was the only immunoglobulin demonstrated to participate in this reaction. The alternative C3 activating pathway is required for efficient heat-labile opsonization of Shigella, but some opsonization also appeared to occur through the C1-C4-C2 pathway of C3 activation.

Mesh:

Substances:

Year:  1975        PMID: 1132888      PMCID: PMC1445889     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  18 in total

1.  Heat labile opsonins to Pneumococcus. 3. The participation of immunoglobulin and of the alternate pathway of C3 activation.

Authors:  J A Winkelstein; H S Shin; W B Wood
Journal:  J Immunol       Date:  1972-06       Impact factor: 5.422

2.  Opsonic activity in human serum deficient in C2.

Authors:  F R Johnson; V Agnello; R C Williams
Journal:  J Immunol       Date:  1972-07       Impact factor: 5.422

3.  The relative antibacterial efficiency of IgM, IgG and IgA from pig colostrum.

Authors:  J Knop; H Breu; P Wernet; D Rowley
Journal:  Aust J Exp Biol Med Sci       Date:  1971-08

4.  Comparative studies of immunoglobulin opsonins in osteomyelitis and other established infections.

Authors:  R C Williams; J H Dossett; P G Quie
Journal:  Immunology       Date:  1969-08       Impact factor: 7.397

5.  Protein purification by affinity chromatography. Derivatizations of agarose and polyacrylamide beads.

Authors:  P Cuatrecasas
Journal:  J Biol Chem       Date:  1970-06       Impact factor: 5.157

6.  Opsonic activity of agammaglobulinemic human sera.

Authors:  R C Williams; P G Quie
Journal:  J Immunol       Date:  1971-01       Impact factor: 5.422

7.  An abnormality of the alternate pathway of complement activation in sickle-cell disease.

Authors:  R B Johnston; S L Newman; A G Struth
Journal:  N Engl J Med       Date:  1973-04-19       Impact factor: 91.245

8.  Complement-dependent opsonization of incompatible erythrocytes by human secretory IgA.

Authors:  M E Kaplan; A P Dalmasso; M Woodson
Journal:  J Immunol       Date:  1972-01       Impact factor: 5.422

9.  Human heat labile opsonins: evidence for their mediation via the alternate pathway of complement activation.

Authors:  H E Jasin
Journal:  J Immunol       Date:  1972-07       Impact factor: 5.422

10.  CHARACTERISTICS OF AN IMMUNE SYSTEM COMMON TO CERTAIN EXTERNAL SECRETIONS.

Authors:  T B TOMASI; E M TAN; A SOLOMON; R A PRENDERGAST
Journal:  J Exp Med       Date:  1965-01-01       Impact factor: 14.307

View more
  13 in total

Review 1.  Receptors for IgA on phagocytic cells.

Authors:  L Shen
Journal:  Immunol Res       Date:  1992       Impact factor: 2.829

Review 2.  The structure and function of human IgA.

Authors:  M A Kerr
Journal:  Biochem J       Date:  1990-10-15       Impact factor: 3.857

3.  The specificity of the human neutrophil IgA receptor (Fc alpha R) determined by measurement of chemiluminescence induced by serum or secretory IgA1 or IgA2.

Authors:  W W Stewart; M A Kerr
Journal:  Immunology       Date:  1990-11       Impact factor: 7.397

4.  Opsonins in human serum for the phagocytosis of complexes between IgG and protein A of Staphylococcus aureus.

Authors:  R Hällgren; G Stålenheim
Journal:  Immunology       Date:  1978-07       Impact factor: 7.397

5.  Thymic independence of adaptive immunity to the intracellular pathogen Shigella flexneri serotype 2a.

Authors:  S S Way; A C Borczuk; M B Goldberg
Journal:  Infect Immun       Date:  1999-08       Impact factor: 3.441

Review 6.  Phagocytosis. Clinical disorders of recognition and ingestion.

Authors:  T P Stossel
Journal:  Am J Pathol       Date:  1977-09       Impact factor: 4.307

7.  Effects of recombinant GM-CSF and IgA opsonisation on neutrophil phagocytosis of latex beads coated with P6 outer membrane protein from Haemophilus influenzae.

Authors:  D Burnett; A Chamba; R A Stockley; T F Murphy; S L Hill
Journal:  Thorax       Date:  1993-06       Impact factor: 9.139

8.  Intransal or intragastric immunization with proteosome-Shigella lipopolysaccharide vaccines protects against lethal pneumonia in a murine model of Shigella infection.

Authors:  C P Mallett; T L Hale; R W Kaminski; T Larsen; N Orr; D Cohen; G H Lowell
Journal:  Infect Immun       Date:  1995-06       Impact factor: 3.441

9.  Characterization of the IgA receptor from human polymorphonuclear leucocytes.

Authors:  M Albrechtsen; G R Yeaman; M A Kerr
Journal:  Immunology       Date:  1988-06       Impact factor: 7.397

10.  Shigella sonnei phase I and phase II: susceptibility to direct serum lysis and opsonic requirements necessary for stimulation of leukocyte redox metabolism and killing.

Authors:  G S Madonna; R C Allen
Journal:  Infect Immun       Date:  1981-04       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.